Bill Ackman may not be bothered by Chipotle Mexican Grill, Inc. (NYSE: CMG)’s latest wave of negative food safety headlines, but other Chipotle customers may not be as quick to forgive.

First tweets say a lot about a person, like what’s worth breaking silence for.

Restaurant Brands International Inc (NYSE: QSR) fell more than 1 percent Wednesday on news that Pershing Square Capital Management divested a 10 million share block.

But the sale wasn't reflective of any negative sentiment toward the company.

Joe Biden, the former vice president who once mused about beating up then-candidate Donald Trump last year, shook his fist at hedge fund trader Bill Ackman and may have even threatened to punch him out during a testy exchange at a ritzy dinner in Las Vegas, repo

Some of the largest and most successful investors in the world presented their best ideas this week at the Ira Sohn Conference in New York. In case you missed it, here’s some of the highlights from Benzinga Pro’s coverage of the event:

“Baby Buffett” may be outgrowing the endearing sobriquet.

Last week, Pershing Square CEO Bill Ackman told Bloomberg he would likely shy away from pharmaceutical companies following his

On April 9, the Wall Street Journal reported, quoting sources, Mondelez International Inc (NASDAQ: MDLZ) is seeking to replace its CEO Irene Rosenfeld.

There has been much talk of Bill Ackman losing his magic touch over his disastrous bets on Valeant Pharmaceuticals Intl Inc (NYSE: VRX), where he lost $4.6 billion, and his infamous short on Herbalife Ltd.(NYSE: HLF), which has gained 22 percent on the year and

U.S. regulators regard Herbalife Ltd. (NYSE: HLF) as a “multi-level marketing scheme,” but Bill Ackman is beyond euphemisms. To Ackman’s Pershing Square Holdings Ltd, the global nutrition company is a “pyramid scheme.”

Shares of Mondelez International Inc (NASDAQ: MDLZ) gained more than 1 percent early Monday morning after the Wall Street Journal reported Sunday that the snack-maker is looking to oust its CEO Irene Rosenfeld.

Billionaire hedge fund manager apologized to investors in a public letter to investors after his hedge fund lost billions of dollars in one trade but is now able to joke about it.

William Cohan, author of 'Why Wall Street Matters,' was a guest on CNBC to talk about

Hedge fund manager Bill Ackman first bought a $3.3 billion stake in Valeant Pharmaceuticals Intl Inc (NYSE: VRX) back in 2015 when the stock was trading north of $200 per share.

Forbes was out with its compilation of the 25 highest-earnings hedge fund managers and traders.

Over the weekend, a court in China issued a favorable ruling in Apple Inc. (NASDAQ: AAPL)'s favor in a patent dispute; Apple can now sell iPhone 6 and 6 Plus devices in the country.

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) investors were disappointed to see that popular vocal activist investor Bill Ackman finally abandoned his stake in Valeant for what was likely nearly a

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)'s refinancing announcement on Tuesday shouldn't be celebrated by investors, at least according to Gadfly's Max Nisen.

Billionaire investor Bill Ackman cut his losses in Valeant Pharmaceuticals Intl Inc (NYSE: VRX)'s stock so now is the time for both the company and hedge fund manager to move on.

Forbes released its ranking of the world's richest people. Ironic or not, just one billionaire in the top 10 earned their fortune through investments and banking: Warren Buffett.

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) plummeted 11 percent Tuesday after notable hedge fund manager Bill Ackman exited his large position of the pharmaceutical company at a loss that could be in the billions of dollars.

After a headline-filled tenure, Bill Ackman's investment in Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is over.

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) fell to a new 52-week low of $10.50 after Bill Ackman sold his stake.

One of the worst chapters of Bill Ackman’s investing career is officially over.

Herbalife Ltd. (NYSE: HLF) shares are up 2.3 percent Monday after Carl Icahn put to rest any speculation that he may be worried about his Herbalife investment ahead of the upcoming release of the “Betting On Zero” documentary.

Back in January, Benzinga published a series of articles where Don Steinbrugge, one of the top experts in the hedge fund industry, shared a preview of the top trends he expects to see among hedge funds in 2017.

QTR Research is the latest firm to weigh in on controversial multi-level marketing nutrition company Herbalife Ltd.

Billionaire investor Carl Icahn's Icahn Enterprises LP (NASDAQ: IEP) announced last Wednesday the hiring of pharma academician Richard Mulligan as a portfolio manager. The announcement has set tongues wagging about Carl Icahn's renewed interest in the pharma/biotech sector.

Astute investors who have mastered the art and science of investing are an elite group to whom an average investor looks up to for portfolio modeling. Given the fickleness associated with the stock market, it's a tough proposition to continuously make money.

Billionaire investor and corporate raider Carl Icahn has trained his eyes on Bristol-Myers Squibb Co (NYSE: BMY).